Pharma-Bio Serv (PBSV) Short Interest Ratio & Short Volume

Short interest is the volume of Pharma-Bio Serv shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 100 shares of PBSV short. 0.00% of Pharma-Bio Serv's shares are currently sold short. Learn More on Pharma-Bio Serv's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Pharma-Bio Serv's floating shares are currently sold short.

Pharma-Bio Serv saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Pharma-Bio Serv's shares are currently sold short. Here is how the short interest of companies in the industry of "business services" compare to Pharma-Bio Serv: Aeries Technology, Inc. (1.17%), WISeKey International Holding Ltd. Sponsored ADR (100.29%), Quest Resource Holding Corporation. (0.65%), Izea Worldwide, Inc. (0.21%), MoneyHero Limited (1.90%), FLUENT, INC. (0.46%), Swvl Holdings Corp. (0.65%), Bioqual Inc. (0.02%), CISO Global, Inc. (2.91%), Janel World Trade Ltd. (0.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

Short selling PBSV is an investing strategy that aims to generate trading profit from Pharma-Bio Serv as its price is falling. PBSV shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Pharma-Bio Serv occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PBSV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBSV, twice per month. The most recent reporting period available is June, 30 2025.